Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-06

FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

The FDA approved Solco Healthcare US, LLC's supplemental application to market a generic donepezil hydrochloride product for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

SUPPL AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)